Atrial fibrillation and stroke. Revisiting the dilemmas

Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial.

European journal of neurology·2020

Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.

Journal of thrombosis and haemostasis : JTH·2015

A Phase II, double-blind, randomized, parallel group, dose-finding study of the safety and tolerability of darexaban compared with warfarin in patients with non-valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL-2).

Journal of thrombosis and haemostasis : JTH·2015

Stroke prevention with rivaroxaban in higher-risk populations with atrial fibrillation.

International journal of clinical practice·2015

Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF.

Journal of clinical pharmacology·2014

Novel oral anticoagulants in secondary prevention of stroke.

Best practice & research. Clinical haematology·2013

Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis.

Stroke·2026

Projection of Stroke Incidence and Costs in China: 2022 to 2050.

Stroke·2026

Thrombus Perviousness Is Associated With Differential Treatment Outcomes Following IVT and EVT in MeVO Stroke.

Stroke·2026

Intraarterial Thrombolysis: Past, Present, Future.

Stroke·2026

Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage: A Placebo-Controlled Trial.

Stroke·2026

Standard Antiplatelet Therapy Versus Thrombolysis in Acute Spontaneous Spinal Cord Infarction: A Propensity Score-Matched Analysis.

Stroke·2026

Associations of Cholesin and GPR146 with atherosclerotic plaque stability: integrated bioinformatics and functional analyses.

Frontiers in cardiovascular medicine·2026

Caveolin-1 levels associated with coronary artery disease in Chinese participants: a retrospective cohort study.

Frontiers in cardiovascular medicine·2026

PCSK9 inhibitors for lipid-lowering treatment in patients with atherosclerotic cardiovascular disease: a health technology assessment.

Frontiers in cardiovascular medicine·2026

Lack of association between Triglyceride glucose-body mass index and glomerular filtration rate in patients with coronary heart disease after percutaneous coronary intervention: a retrospective case-control study.

Frontiers in endocrinology·2026

Association of the TyG index and inflammatory burden index with AMR-defined coronary microvascular dysfunction and 12-month MACE after STEMI.

Frontiers in endocrinology·2026

Correlation of Cystatin C- and Creatinine-Based Renal Equations With Lipid Parameters in Chronic Kidney Disease: A Case-Control Study.

Cureus·2026

Related Experiment Videos

Atrial fibrillation and stroke. Revisiting the dilemmas

Related Concept Videos

Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial.

Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.

A Phase II, double-blind, randomized, parallel group, dose-finding study of the safety and tolerability of darexaban compared with warfarin in patients with non-valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL-2).

Stroke prevention with rivaroxaban in higher-risk populations with atrial fibrillation.

Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF.

Novel oral anticoagulants in secondary prevention of stroke.

Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis.

Projection of Stroke Incidence and Costs in China: 2022 to 2050.

Thrombus Perviousness Is Associated With Differential Treatment Outcomes Following IVT and EVT in MeVO Stroke.

Intraarterial Thrombolysis: Past, Present, Future.

Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage: A Placebo-Controlled Trial.

Standard Antiplatelet Therapy Versus Thrombolysis in Acute Spontaneous Spinal Cord Infarction: A Propensity Score-Matched Analysis.

Associations of Cholesin and GPR146 with atherosclerotic plaque stability: integrated bioinformatics and functional analyses.

Caveolin-1 levels associated with coronary artery disease in Chinese participants: a retrospective cohort study.

PCSK9 inhibitors for lipid-lowering treatment in patients with atherosclerotic cardiovascular disease: a health technology assessment.

Lack of association between Triglyceride glucose-body mass index and glomerular filtration rate in patients with coronary heart disease after percutaneous coronary intervention: a retrospective case-control study.

Association of the TyG index and inflammatory burden index with AMR-defined coronary microvascular dysfunction and 12-month MACE after STEMI.

Correlation of Cystatin C- and Creatinine-Based Renal Equations With Lipid Parameters in Chronic Kidney Disease: A Case-Control Study.

Related Experiment Videos

Atrial fibrillation and stroke. Revisiting the dilemmas

Related Concept Videos

Related Articles